Rezultati pretraživanja
  1. new publication: Familial pulmonary arterial hypertension by KDR heterozygous loss of function. .

  2. 3. velj

    announces sotatercept achieved primary and secondary endpoints in the PULSAR trial

  3. 1. velj
  4. 30. sij

    Reliability and responsiveness of incremental shuttle walk test to estimate exercise capacity in patients with pulmonary arterial hypertension R. Ishrat, A. Mujaddadi, M.S. Ali, D. Talwar, M.E. Hussain

  5. 29. sij

    This drug didn't pan out treating a rare blood disorder or chronic kidney disease. But with positive topline Phs 2 data in , some now see blockbuster potential. shares shot up 50% Tues.

  6. new publication: Safety of riociguat for the treatment of pulmonary arterial hypertension: Final data cut from the expert registry. .

  7. 29. sij

    Noninvasive prognostic biomarkers for left as predictors of survival in |

  8. 27. sij
  9. 27. sij

    Results of an Expert Delphi Consensus Survey on clinical scenarios considered when initiating oral prostacyclin pathway agents in the treatment of . Learn more:

  10. 27. sij

    “Bosentan Tablets, 62.5 mg and 125 mg have an estimated market size of $68 million for twelve months ending September 2019.”

  11. new publication: Estrogen imbalance in patients with pulmonary arterial hypertension: Profiling metabolites using LC-MS/MS. .

  12. 25. sij
  13. 24. sij
  14. 24. sij

    Of all these breakouts, I seek all of you, say prayers to our 1st frontliners, doctors, nurses, healthcare workers whose facing this tough time.

    Prikaži ovu nit
  15. 23. sij

    Identifying Genetic Origins of Pulmonary Arterial Hypertension in Children

  16. 23. sij
  17. 18. sij
  18. 17. sij

    Can This Hormone That Regulates Sleep Treat Pulmonary Arterial Hypertension Symptoms?

  19. 17. sij
  20. 15. sij

    New in AJP-Lung: “BMPR2 dysfunction impairs signaling and glucose homeostasis in ”. Read more here:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.